Acceso abierto

Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors

Maria Ingenerf

Maria Ingenerf

Department of Radiology, University Hospital, LMU MunichGermany
Buscar este autor en
Sciendo|Google Scholar
Ingenerf, Maria
, 
Christoph Auernhammer

Christoph Auernhammer

  • ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
  • Department of Internal Medicine 4, University Hospital, LMU MunichMunich, Germany
Buscar este autor en
Sciendo|Google Scholar
Auernhammer, Christoph
, 
Roberto Lorbeer

Roberto Lorbeer

Department of Radiology, University Hospital, LMU MunichGermany
Buscar este autor en
Sciendo|Google Scholar
Lorbeer, Roberto
, 
Michael Winkelmann

Michael Winkelmann

Department of Radiology, University Hospital, LMU MunichGermany
Buscar este autor en
Sciendo|Google Scholar
Winkelmann, Michael
, 
Shiwa Mansournia

Shiwa Mansournia

Department of Radiology, University Hospital, LMU MunichGermany
Buscar este autor en
Sciendo|Google Scholar
Mansournia, Shiwa
, 
Nabeel Mansour

Nabeel Mansour

Department of Radiology, University Hospital, LMU MunichGermany
Buscar este autor en
Sciendo|Google Scholar
Mansour, Nabeel
, 
Nina Hesse

Nina Hesse

Department of Radiology, University Hospital, LMU MunichGermany
Buscar este autor en
Sciendo|Google Scholar
Hesse, Nina
, 
Kathrin Heinrich

Kathrin Heinrich

Department of Medicine III, University Hospital, University of MunichMunich, Germany
Buscar este autor en
Sciendo|Google Scholar
Heinrich, Kathrin
, 
Jens Ricke

Jens Ricke

  • Department of Radiology, University Hospital, LMU MunichGermany
  • ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Buscar este autor en
Sciendo|Google Scholar
Ricke, Jens
, 
Frank Berger

Frank Berger

Department of Radiology, University Hospital, LMU MunichGermany
Buscar este autor en
Sciendo|Google Scholar
Berger, Frank
 y 
Christine Schmid-Tannwald

Christine Schmid-Tannwald

  • Department of Radiology, University Hospital, LMU MunichGermany
  • ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Buscar este autor en
Sciendo|Google Scholar
Schmid-Tannwald, Christine
  
14 abr 2024
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Categoría del artículo: Research Article
Publicado en línea: 14 abr 2024
Páginas: 196 - 205
Recibido: 08 dic 2023
Aceptado: 20 feb 2024
DOI: https://doi.org/10.2478/raon-2024-0024
Palabras clave
© 2024 Maria Ingenerf et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicina, Medicina Clínica, Medicina Interna, Hematología, oncología, Radiología
RSS Feed de revista